Unique ID issued by UMIN | UMIN000021330 |
---|---|
Receipt number | R000024596 |
Scientific Title | The efficiency of Ramucirumab therapy for advanced gastric cancer after chemotherapy |
Date of disclosure of the study information | 2016/06/01 |
Last modified on | 2016/03/04 09:25:50 |
The efficiency of Ramucirumab therapy for advanced gastric cancer after chemotherapy
Ramuciru-AC
The efficiency of Ramucirumab therapy for advanced gastric cancer after chemotherapy
Ramuciru-AC
Japan |
gastric cancer
Gastroenterology |
Malignancy
YES
Objective is to examine the efficiency for the treatment of gastric cancer.
Efficacy
Exploratory
Pragmatic
Phase IV
PSF,RR,OS
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine | Device,equipment |
Try Ramucirumab monotherapy for gastric cancer.
Over a period of 60 minutes once Ramucirumab 8mg / kg for intravenous infusion every two weeks.
Administration of Ramucirumab will continue until worsen of disease.
20 | years-old | <= |
95 | years-old | > |
Female
Patients who were received all kind of chemotherapy as much as possible
serious underlying disease
10
1st name | |
Middle name | |
Last name | Tomoyuki Shibata |
Fujita Health University
Gastroenterology
1-98 Denagakugakubo, Kutsukake-cho, Toyoake 470-1192, Japan
+81-562-93-9240
tshibata-04@umin.ac.jp
1st name | |
Middle name | |
Last name | Tomoyuki Shibata |
Fujita Health University
Gastroenterology
1-98 Denagakugakubo, Kutsukake-cho, Toyoake 470-1192, Japan
+81-562-93-9240
tshibata-04@umin.ac.jp
Fujita Health University Hospital
Fujita Health University Hospital
Other
NO
2016 | Year | 06 | Month | 01 | Day |
Unpublished
Preinitiation
2015 | Year | 10 | Month | 31 | Day |
2016 | Year | 06 | Month | 01 | Day |
2016 | Year | 03 | Month | 04 | Day |
2016 | Year | 03 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024596